(19)
RU
(11)
2 236 007
(13)
C1
(51)
IPC
(21) (22)
Application
2003118152/15, 2003-06-16
(24)
Start date
2003-06-16
(22)
Actual filing date
(45)
Published
2004-09-10
(72)
Inventor
Aznabaev M.T.Gazdalieva L.M.Nikitin N.A.Dautova Z.A.
(73)
Holder
Ufimskij Nauchno-Issledovatel'Skij Institut Glaznykh Boleznej
FIELD: medicine.
SUBSTANCE: method involves determining total amount of final metabolites of nitrogen oxide (NO-2/NO-3). NO-2/NO-3 concentration in lacrimal fluid being found above 1.0 mcmole/l, disease development course is estimated as favorable. NO-2/NO-3 concentration in lacrimal fluid being found below 1.0 mcmole/l, disease development course is estimated as unfavorable.
EFFECT: high accuracy of early stage prognosis.
Authors
Aznabaev M.T.
Gazdalieva L.M.
Nikitin N.A.
Dautova Z.A.
Dates
2004-09-10—Published
2003-06-16—Filed